{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:46:08Z","timestamp":1794642368279,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Mesonephric carcinoma is a rare malignancy, thought to derive from Wolffian remnants. To date, no targeted molecular therapeutic options have been identified. On the basis of limited case reports, c-KIT immunohistochemical expression has been reported in female adnexal tumors of Wolffian origin, and targeted therapy with Imatinib has been attempted with mixed success. Currently, it is unclear whether c-KIT immunohistochemical expression is seen in mesonephric carcinoma, a tumor that is thought to be related to female adnexal tumors of Wolffian origin, and how this correlates with <jats:italic toggle=\"yes\">KIT<\/jats:italic> mutational status. In this study, we assessed the immunohistochemical expression of c-KIT and <jats:italic toggle=\"yes\">KIT<\/jats:italic> mutational status, in a series of 13 mesonephric neoplasms (5 cervical [including 2 cervical carcinosarcomas], 3 uterine corpora, 4 ovarian, and 1 vaginal\/pelvic). The intensity of staining and proportion of cells showing cytoplasmic\/membranous staining for c-KIT were recorded. <jats:italic toggle=\"yes\">KIT<\/jats:italic> was sequenced using a next-generation sequencing panel that targeted 120 hotspots and 17 exons in 33 known actionable cancer genes. This panel included <jats:italic toggle=\"yes\">KIT<\/jats:italic> exons 9, 11, and 13, and 6 hotspots (T670, D816, D820, N822, Y823, A829). Although c-KIT immunohistochemical expression was observed in the majority of mesonephric carcinomas (10\/12 cases; 83%), no <jats:italic toggle=\"yes\">KIT<\/jats:italic> mutations were detected. This cautions pathologists against the use of c-KIT immunohistochemistry as a surrogate marker for <jats:italic toggle=\"yes\">KIT<\/jats:italic>-activating mutations in this setting. Consistent with previous studies, the majority of mesonephric neoplasms (10\/13; 77%) harbored <jats:italic toggle=\"yes\">KRAS<\/jats:italic> mutations. Additional mutations were found in <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic> (2\/13, 15%), <jats:italic toggle=\"yes\">TP53<\/jats:italic> (2\/13, 15%), and <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic> (1\/13, 8%).<\/jats:p>","DOI":"10.1097\/pas.0000000000001403","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T10:23:35Z","timestamp":1573554215000},"page":"495-502","source":"Crossref","is-referenced-by-count":20,"title":["c-KIT Analysis and Targeted Molecular Sequencing of Mesonephric Carcinomas of the Female Genital Tract"],"prefix":"10.1097","volume":"44","author":[{"given":"Jennifer","family":"Pors","sequence":"first","affiliation":[{"name":"Department of Anatomical Pathology, Vancouver General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ho","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Prentice","sequence":"additional","affiliation":[{"name":"Contextual Genomics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Vancouver General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Gibbard","sequence":"additional","affiliation":[{"name":"Medical Genetics, University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[{"name":"Contextual Genomics"},{"name":"Department of Molecular Oncology, British Columbia Cancer Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Vancouver General Hospital"},{"name":"Pathology and Laboratory Medicine"},{"name":"Genetic Pathology Evaluation Center (GPEC), Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn N.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Vancouver General Hospital"},{"name":"Pathology and Laboratory Medicine"},{"name":"Medical Genetics, University of British Columbia"},{"name":"Genetic Pathology Evaluation Center (GPEC), Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.humpath.2018.08.018","article-title":"Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma","volume":"86","author":"Patel","year":"2019","journal-title":"Hum Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gore.2016.05.002","article-title":"Mesonephric adenocarcinoma of the cervix: case report and literature review","volume":"17","author":"Dierickx","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"pii:bcr0120125632","DOI":"10.1136\/bcr.01.2012.5632","article-title":"Mesonephric adenocarcinoma of the uterine cervix and literature review","volume":"2012","author":"Anagnostopoulos","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0046-8177(99)90148-X","article-title":"Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin","volume":"30","author":"Devouassoux-Shisheboran","year":"1999","journal-title":"Hum Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1066896907307034","article-title":"Wolffian tumor of the ovary with a prominent spindle cell component: report of a case with brief discussion of unusual problems in differential diagnosis, and literature review","volume":"16","author":"Li","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1440-1827.2006.01930.x","article-title":"Female adnexal tumor of probable wolffian origin: morphological, immunohistochemical, and ultrastructural study with c-kit gene analysis","volume":"56","author":"Harada","year":"2006","journal-title":"Pathol Int"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1048-891x.2004.014319.x","article-title":"Female adnexal tumor of probable Wolffian origin: a clinicopathological case report and a possible new treatment","volume":"14","author":"Steed","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PGP.0b013e3182005340","article-title":"Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery","volume":"30","author":"Syriac","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3892\/ol.2017.5874","article-title":"Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel\/carboplatin combination chemotherapy: a case report","volume":"13","author":"Wakayama","year":"2017","journal-title":"Oncol Lett"},{"key":"R18-20230922","first-page":"46","article-title":"Female adnexal tumors of probable Wolffian origin with a biphasic histologic growth pattern and positive for c-kit","volume":"4","author":"Zhang","year":"2016","journal-title":"Hum Pathol: Case Rep"},{"key":"R19-20230922","first-page":"357027","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother Res Pract"},{"key":"R20-20230922","first-page":"3329","article-title":"Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors","volume":"9","author":"Antonescu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJMe1700833","article-title":"Imatinib changed everything","volume":"376","author":"Longo","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent kras mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"e0196434","DOI":"10.1371\/journal.pone.0196434","article-title":"Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice","volume":"13","author":"Prentice","year":"2018","journal-title":"PLoS One"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/PGP.0000000000000368","article-title":"Female adnexal tumors of probable Wolffian origin (FATWO): a case series with next-generation sequencing mutation analysis","volume":"36","author":"Cossu","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/a-0746-8985","article-title":"Female adnexal tumour of probable Wolffian origin (FATWO): review of the literature","volume":"79","author":"H\u00fcbner","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/PGP.0000000000000545","article-title":"Targeted genomic profiling of female adnexal tumors of probable Wolffian origin (FATWO)","volume":"38","author":"Mirkovic","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/gyno.2002.6739","article-title":"Wolffian duct tumors: case reports and review of the literature","volume":"86","author":"Ramirez","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/modpathol.3800159","article-title":"CD117 expression in mesothelioma","volume":"17","author":"Arber","year":"2004","journal-title":"Mod Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.MP.0000083647.69123.5C","article-title":"c-Kit is not expressed in malignant mesothelioma","volume":"16","author":"Horvai","year":"2003","journal-title":"Mod Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1177\/42.11.7523489","article-title":"Expression of c-kit and kit ligand proteins in normal human tissues","volume":"42","author":"Lammie","year":"1994","journal-title":"J Histochem Cytochem"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00193492","article-title":"Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma\/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues","volume":"424","author":"Tsuura","year":"1994","journal-title":"Virchows Arch"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1078-0432.CCR-08-2243","article-title":"Overexpression of the KIT\/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate","volume":"15","author":"Hofmann","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/jcp.2007.046441","article-title":"c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours","volume":"60","author":"Jones","year":"2007","journal-title":"J Clin Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00000478-200204000-00011","article-title":"C-kit expression in pediatric solid tumors: a comparative immunohistochemical study","volume":"26","author":"Smithey","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2013.199","article-title":"Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement","volume":"27","author":"Lee","year":"2014","journal-title":"Mod Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1200\/jco.2010.28.15_suppl.8527","article-title":"A phase II study of imatinib for advanced melanoma patients with KIT aberrations","volume":"28","author":"Guo","year":"2010","journal-title":"J Clin Oncol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2007.14.5540","article-title":"Intracranial collision metastases of small-cell lung cancer and malignant melanoma","volume":"26","author":"Palka","year":"2008","journal-title":"J Clin Oncol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/cncr.21834","article-title":"Multicenter phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy","volume":"106","author":"Wyman","year":"2006","journal-title":"Cancer"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0000000000000306","article-title":"Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix: case description of a previously unreported entity with insights into its molecular pathogenesis","volume":"36","author":"Cavalcanti","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a m\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R43-20230922","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a mullerian origin of mesonephric-like adenocarcinoma","author":"McCluggage","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.28288","article-title":"Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13000-019-0847-8","article-title":"Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis","volume":"14","author":"Montalvo","year":"2019","journal-title":"Diagn Pathol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/1097-0142(197303)31:3<671::AID-CNCR2820310328>3.0.CO;2-K","article-title":"Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity","volume":"31","author":"Kariminejad","year":"1973","journal-title":"Cancer"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000478-198303000-00002","article-title":"Ovarian tumors of probable Wolffian origin. A report of 11 cases","volume":"7","author":"Young","year":"1983","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:58:29Z","timestamp":1695423509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001403","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,8]]}}}